why choose us

First received: March 24, 2023

Clinical Trial: Open-label, Randomized, 2-way Crossover, Monocentric, Controlled Study to Evaluate the Effect on Daily PHE Fluctuation of PKU GOLIKE Versus SoC in Patients With PKU.

Study Status: Completed

Recruit Status: RECRUITING

Condition: Phenylketonurias

Study Type: INTERVENTIONAL


Official Title: Open-label, Randomized, 2-way Crossover, Monocentric, Controlled Study to Evaluate the Effect on Daily PHE Fluctuation of PKU GOLIKE Versus Standard of Care in Patients With Phenylketonuria

Brief Summary: This is an open-label, randomized, 2-way crossover, monocentric controlled study in patients (? 16 years old) with phenylketonuria (PKU).The comparison will be between the test product (PKU GOLIKE, a prolonged-release amino-acids (AAs) mixture) and standard of care.

Read more